Vivo Capital »

Lb Pharmaceuticals shares owned by Vivo Capital

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 800k 15.79

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Cidara Therapeutics Common (CDTX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Cogent Biosciences Common (COGT)
Sinovac Biotech SHS
Oric Pharmaceuticals Common (ORIC)
Geron Corp Common (GERN)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Bright Minds Biosciences Common (DRUG)
Tourmaline Bio Common (TRML)

View all positions for Vivo Capital

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals